Biotech Stocks

as a group started the year out strong but have been hit hard over the last week. Now the Biotech Holders (BBH) look like they may be in a good low risk area for a new purchase and shares of Genentech (DNA)appear to be in an even better position after having just reported better than expected earnings. Make sure you view my video analysis of BBH and DNA when you view WALLSTRIP this morning.

TROUBLE VIEWING?